Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment

Background: This study estimated utility values for non-alcoholic steatohepatitis (NASH). Previous studies have assumed that health-related quality of life does not vary between the early stages of NASH. Materials &Methods: Discrete choice experiment (DCE) surveys estimated the value of avoiding...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Aggio (Author), Katy Gallop (Author), Villum Wittrup-Jensen (Author), Soulmaz Fazeli Farsani (Author), Andrew J Lloyd (Author)
Format: Book
Published: Becaris Publishing Limited, 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: This study estimated utility values for non-alcoholic steatohepatitis (NASH). Previous studies have assumed that health-related quality of life does not vary between the early stages of NASH. Materials &Methods: Discrete choice experiment (DCE) surveys estimated the value of avoiding fibrosis progression. Patients also completed the EQ-5D-5L. Marginal rates of substitution estimated utility change associated with fibrosis progression. Results: DCE surveys were completed by the UK general public (n = 520) and patients with NASH (n = 154). The utility decline between fibrosis stages F1 and F4 decompensated was between -0.521 to -0.646 (depending on method). Conclusion: Three methods were used to estimate utilities for NASH, each one showed sensitivity to advancing fibrosis, including in the early stages, which is often considered asymptomatic.
Item Description:10.57264/cer-2023-0033
2042-6313